Full-Time

Account Executive - Chronic Therapies

Multiple Teams

Posted on 9/3/2025

Option Care Health

Option Care Health

1,001-5,000 employees

Largest independent home infusion therapy provider

Compensation Overview

$104.5k - $174.2k/yr

Boston, MA, USA

In Person

US Citizenship Required

Category
Sales & Account Management (1)
Required Skills
Customer Service
Requirements
  • Bachelor’s degree and a minimum of 3 years of recent experience in office-based physician sales with a proven track record of success, OR,
  • Bachelor’s degree and a minimum of 3 years of recent chronic infusion healthcare experience, OR
  • High school diploma and a minimum of 5 years of recent experience in office-based physician sales with a proven track record of success.
  • Proficient in territory analysis and planning
  • Results-oriented mindset with expertise in the complete selling cycle (call objectives, opening statements, listening, use of questions, feature & benefit statements, use of visual aids, objection handling, closing, post-call analysis)
  • Experience developing and managing business relationships with physician office practices
Responsibilities
  • Identify, establish, and maintain professional relationships with targeted physician groups and office staff members to maximize business opportunities. Demonstrate the awareness of their needs and respond with appropriate action
  • Demonstrate effective selling skills during physician and/or office staff presentations with existing and potential customers.
  • Consult with clinicians as well as medical office staff (i.e. biologics coordinator) to appropriately promote Option Care Health and provide industry-leading customer service
  • Review and analyze all available sales data in order to create effective territory plans and utilize promotional budget funds.
  • Establish and maintain strong relationships with regional branch team members to ensure alignment and support of sales efforts
  • Maintain a call average as outlined in the sales plan, defined as face-to-face interactions with healthcare providers, focusing on top target customers
  • Achieve all sales performance goals and objectives for geographical responsibility
  • Show expertise in local market dynamics (competition, payers, therapies) as well as complex disease states Option Care Health services
  • Work cross-functionally to resolve issues in the best manner for Option Care Health customers
  • Proven record of accomplishments in the home infusion market.
  • Well-developed written and oral communication skills
  • Apply a range of problem-solving techniques to solve issues creatively to improve performance and company effectiveness
  • Adhere to all compliance policies and guidelines of Option Care Health
Desired Qualifications
  • Home infusion experience preferred
  • Specialty healthcare products experience preferred
  • Broad therapeutic area experience preferred
  • Knowledge of reimbursement, managed care, or marketing preferred

Option Care Health delivers infusion therapies at home and other alternate-site locations across the United States, supported by over 7,000 teammates including about 4,500 clinicians. Clinicians visit patients at home or approved sites to administer therapies, manage care, and coordinate with care teams under strong clinical leadership and national scale. It stands out as the largest independent infusion provider with nationwide reach and a robust clinical workforce, enabling scalable home and alternate-site infusion rather than hospital-only care. The goal is to elevate standards of care and reimagine the infusion care experience by expanding access, improving outcomes, and delivering compassionate, clinically driven service.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Norfolk, Virginia

Founded

1979

Simplify Jobs

Simplify's Take

What believers are saying

  • Expanded revolving credit facility to $850 million enables M&A flexibility.
  • Increased share repurchase authorization to $1 billion signals management confidence.
  • Operating cash flow exceeds $340 million in 2026, growing over 30%.

What critics are saying

  • Chronic Inflammatory Disease portfolio reset causes $55 million revenue headwind through 2026.
  • Stelara biosimilars and Inflation Reduction Act cut gross profit by $25-35 million.
  • EEOC pregnancy discrimination lawsuit triggers fines and talent exodus by 2027.

What makes Option Care Health unique

  • Largest national independent provider of home and alternate site infusion services.
  • Serves over 315,000 unique patients with high-quality infusion therapy options.
  • Selected by Quince Therapeutics for specialty infusion of lead asset eDSP.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Time Off

Bonding Time Off

401(k) Retirement Plan

401(k) Company Match

Health Savings Account/Flexible Spending Account

Flexible Spending Accounts

Tuition Reimbursement

Family Support

Mental Health Support

Company Paid Life Insurance

Award/Recognition Programs

Company News

Simply Wall St
Apr 4th, 2026
Option Care Health expands credit facility to $850M, boosts buyback to $1B

Option Care Health has expanded its revolving credit facility by $450 million to $850 million and increased its share repurchase authorisation to $1 billion, whilst reaffirming its 2026 guidance. The moves strengthen liquidity and signal management confidence in cash generation. The expanded buyback and credit facility provide greater flexibility for growth investments and capital returns, though near-term focus remains on executing guidance and managing reimbursement pressures. The company's narrative projects $7 billion revenue and $302.2 million earnings by 2029, implying 7.5% annual revenue growth. Analyst fair value estimates range widely from $3.66 to $40.09 per share, with the upper estimate suggesting 46% upside from current prices.

MicroCare
Mar 9th, 2026
MicroCare Medical welcomes Matt Lingenfelter as national sales manager, healthcare.

MicroCare Medical welcomes Matt Lingenfelter as national sales manager, healthcare. March 09, 2026 MicroCare Medical is pleased to welcome Matt Lingenfelter as national sales manager, healthcare. With more than 20 years of experience in healthcare sales and leadership, Matt will help drive national growth and strengthen partnerships for the MicroCare Medical instrument care and infection prevention solutions. In this role, Matt will guide healthcare sales strategy across the U.S., focusing on expanding key accounts, building strong distributor relationships, and supporting the sales team. He will also work closely with marketing, operations, and product development to ensure MicroCare continues delivering solutions that meet the evolving needs of healthcare professionals. Before joining MicroCare, Matt held leadership roles with Option Care Health, Belimed, and Aesculap, where he developed deep expertise in surgical instrumentation, endoscopic technologies, and hospital system support. "Matt's experience and understanding of healthcare systems make him a fantastic addition to our team," said Ray Bellavance, vice president of global sales and marketing at MicroCare. "We're excited to have him help grow our healthcare business and strengthen partnerships across the country."

Yahoo Finance
Feb 27th, 2026
Option Care Health posts 13% revenue growth despite $25M–35M Stelara biosimilar headwind

Option Care Health reported a 13% revenue increase in Q4 2025, with acute therapies growing in the mid-teens and chronic therapies in the low double digits. The company served over 315,000 unique patients and improved operational efficiency, with 40% of claims now processed without human intervention. For 2026, the company issued revenue guidance of $5.8 billion to $6 billion, incorporating a 400 basis point headwind from Stelara biosimilar conversions and Inflation Reduction Act impacts. Adjusted EBITDA is projected at $480 million to $505 million, accounting for a $25 million to $35 million gross profit headwind from Stelara transitions. Operating cash flow is expected to exceed $340 million, representing over 30% growth. The company plans to launch at least two new pharmaceutical manufacturer programmes and expand its infusion clinic model to support higher-acuity therapies.

PREEMPT, Inc
Sep 30th, 2025
EEOC Sues Option Care Health, Inc. for Pregnancy Discrimination

EEOC sues Option Care Health, Inc. for pregnancy discrimination.

Option Care Health
Aug 7th, 2025
Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for Administration of Lead Asset eDSP

Quince Therapeutics selects Option Care Health as specialty infusion therapy provider for administration of lead asset eDSP.

INACTIVE